The vasodilatory effect of testosterone on renal afferent arterioles

Gender Medicine

Volumn 9, Issue 2, 2012, Pages 103-111

  Lu, Yan ^a   Fu, Yiling ^a   Ge, Ying ^a   Juncos, Luis A ^a   Reckelhoff, Jane F ^a   Liu, Ruisheng ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

androgen receptors; kidney; nitric oxide; testosterone

Indexed keywords

4 AMINO 5 METHYLAMINO 2',7' DIFLUOROFLUORESCEIN DIACETATE; ANDROGEN RECEPTOR; FLUORESCENT DYE; FLUTAMIDE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; TESTOSTERONE; UNCLASSIFIED DRUG;

AFFERENT ARTERIOLE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY DIAMETER; ARTERY PERFUSION; ARTERY WALL; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; MALE; MICRODISSECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENAL ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASODILATATION;

ANIMALS; ARTERIOLES; GENE EXPRESSION; KIDNEY; MICE; NITRIC OXIDE; RECEPTORS, ANDROGEN; RENAL ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTOSTERONE; VASODILATION; VASODILATOR AGENTS;

EID: 84862794284     PISSN: 15508579     EISSN: 18787398     Source Type: Journal    
DOI: 10.1016/j.genm.2012.02.003     Document Type: Article

References (38)

1. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37: 1199-208. (Pubitemid 34163570)
2. Luczak ED, Leinwand LA. Sex-based cardiac physiology. Annu Rev Physiol 2009;71:1-18.
3. Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med. 2008;5(Suppl A): S3-S10. (Pubitemid 351455227)
4. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000; 11:319 -329.
5. Berg UB. Differences in decline in GFR with age between males and females: reference data on clearances of insulin and PAH in potential kidney donors. Nephrol Dial Transplant. 2006;21:2577-2582. (Pubitemid 44644534)
6. Perusquia M, Stallone JN. Do androgens play a beneficial role in the regulation of vascular tone? nongenomic vascular effects of testosterone metabolites. Am J Physiol Heart Circ Physiol. 2010;298: H1301-H1307.
7. Yildiz O, Seyrek M. Vasodilating mechanisms of testosterone. Exp Clin Endocrinol Diabetes. 2007; 115(1):1- 6.
8. Webb CM, McNeill JG, Hayward CS, et al. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation. 1999;100:1690-1696. (Pubitemid 29485250)
9. Pugh PJ, Jones TH, Channer KS. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J. 2003;24:909-915. (Pubitemid 36559984)
10. Malkin CJ, Jones RD, Jones TH, Channer KS. Effect of testosterone on ex vivo vascular reactivity in man. Clin Sci (Lond). 2006;111:265-274. (Pubitemid 44599873)
11. Yue P, Chatterjee K, Beale C, et al. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 1995;91:1154-1160.
12. Ding AQ, Stallone JN. Testosterone-induced relaxation of rat aorta is androgen structure specific and involves K+ channel activation. J Appl Physiol. 2001;91:2742-2750. (Pubitemid 33108041)
13. Teoh H, Quan A, Leung SW, Man RY. Differential effects of 17beta-estradiol and testosterone on the contractile responses of porcine coronary arteries. Br J Pharmacol. 2000;129:1301-1308. (Pubitemid 30175701)
14. Tep-areenan P, Kendall DA, Randall MD. Testosterone- induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br J Pharmacol. 2002;135:735-740. (Pubitemid 34177651)
15. Chou TM, Sudhir K, Hutchison SJ, et al. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 1996;94:2614-2619. (Pubitemid 26403593)
16. English KM, Jones RD, Jones TH, et al. Testosterone acts as a coronary vasodilator by a calcium antagonistic action. J Endocrinol Invest. 2002; 25:455-458. (Pubitemid 34516593)
17. Carmines PK, Inscho EW, Gensure RC. Arterial pressure effects on preglomerular microvasculature of juxtamedullary nephrons. Am J Physiol. 1990;258:F94-F102. (Pubitemid 20063074)
18. Marrachelli VG, Miranda FJ, Centeno JM, et al. Mechanisms involved in the relaxant action of testosterone in the renal artery from male normoglycemic and diabetic rabbits. Pharmacol Res. 2010; 61:149-156.
19. Ren Y, D'Ambrosio MA, Liu R, et al. Enhanced myogenic response in the afferent arteriole of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2010;298:H1769-H1775.
20. Liu R, Ren Y, Garvin JL, Carretero OA. Superoxide enhances tubuloglomerular feedback by constricting the afferent arteriole. Kidney Int. 2004;66: 268-274. (Pubitemid 38870102)
21. Ito S, Arima S, Juncos LA, Carretero OA. Endothelium- derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest. 1993;91:2012-2019. (Pubitemid 23141473)
22. Chang C, Saltzman A, Yeh S, et al. Androgen receptor: an overview. Crit Rev Eukaryot Gene Expr. 1995;5:97-125.
23. Reckelhoff JF, Zhang H, Granger JP. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension. 1998;31:435-439.
24. Song J, Eyster KM, Kost CK Jr, et al. Involvement of protein kinase C-CPI-17 in androgen modulation of angiotensin II-renal vasoconstriction. Cardiovasc Res. 2010;85:614-621.
25. Vasudevan H, Yuen VG, McNeill JH. Testosterone-dependent increase in blood pressure is mediated by elevated Cyp4A expression in fructose-fed rats. Mol Cell Biochem. 2012;359:409-418.
26. Boulkroun S, Le MC, Blot-Chabaud M, et al. Expression of androgen receptor and androgen regulation of NDRG2 in the rat renal collecting duct. Pflugers Arch. 2005;451:388-394. (Pubitemid 41586714)
27. Prabhu A, Xu Q, Manigrasso MB, et al. Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes. Steroids. 2010;75:779-787.
28. Perusquia M, Navarrete E, Gonzalez L, Villalon CM. The modulatory role of androgens and progestins in the induction of vasorelaxation in human umbilical artery. Life Sci. 2007;81:993-1002. (Pubitemid 47393568)
29. Deenadayalu VP, White RE, Stallone JN, et al. Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol. 2001;281:H1720-H1727.
30. Seyrek M, Yildiz O, Ulusoy HB, Yildirim V. Testosterone relaxes isolated human radial artery by potassium channel opening action. J Pharmacol Sci. 2007;103:309-316. (Pubitemid 46465774)
31. Yildiz O, Seyrek M, Gul H, et al. Testosterone relaxes human internal mammary artery in vitro. J Cardiovasc Pharmacol. 2005;45:580-585. (Pubitemid 40734580)
32. Ceballos G, Figueroa L, Rubio I, et al. Acute and nongenomic effects of testosterone on isolated and perfused rat heart. J Cardiovasc Pharmacol. 1999;33:691-697. (Pubitemid 29196705)
33. Rowell KO, Hall J, Pugh PJ, et al. Testosterone acts as an efficacious vasodilator in isolated human pulmonary arteries and veins: evidence for a biphasic effect at physiological and supra-physiological concentrations. J Endocrinol Invest. 2009;32:718-723.
34. Falkenstein E, Tillmann HC, Christ M, et al. Multiple actions of steroid hormones: a focus on rapid, nongenomic effects. Pharmacol Rev. 2000;52:513-556.
35. Gorczynska E, Handelsman DJ. Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells. Endocrinology. 1995;136: 2052-2059.
36. Steinsapir J, Socci R, Reinach P. Effects of androgen on intracellular calcium of LNCaP cells. Biochem Biophys Res Commun. 1991;179:90-96.
37. Jones RD, Pugh PJ, Hall J, et al. Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouse. Eur J Endocrinol. 2003;148:111-120. (Pubitemid 36176011)
38. Kouloumenta V, Hatziefthimiou A, Paraskeva E, et al. Non-genomic effect of testosterone on airway smooth muscle. Br J Pharmacol. 2006;149:1083-1091. (Pubitemid 44950811)